- Home
- DERM vs STEX Comparison
DERM vs STEX Comparison
Compare DERM & STEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- STEX
- Stock Information
- Founded
- DERM 2014
- STEX 2009
- Country
- DERM United States
- STEX United States
- Employees
- DERM N/A
- STEX N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- STEX
- Sector
- DERM Health Care
- STEX
- Exchange
- DERM Nasdaq
- STEX Nasdaq
- Market Cap
- DERM 213.6M
- STEX 172.1M
- IPO Year
- DERM 2021
- STEX N/A
- Fundamental
- Price
- DERM $7.85
- STEX $4.48
- Analyst Decision
- DERM Strong Buy
- STEX Strong Buy
- Analyst Count
- DERM 3
- STEX 1
- Target Price
- DERM $12.67
- STEX $12.00
- AVG Volume (30 Days)
- DERM 236.1K
- STEX 754.8K
- Earning Date
- DERM 11-12-2025
- STEX 11-14-2025
- Dividend Yield
- DERM N/A
- STEX N/A
- EPS Growth
- DERM N/A
- STEX N/A
- EPS
- DERM N/A
- STEX N/A
- Revenue
- DERM $59,399,000.00
- STEX $13,000.00
- Revenue This Year
- DERM $26.16
- STEX N/A
- Revenue Next Year
- DERM $45.27
- STEX N/A
- P/E Ratio
- DERM N/A
- STEX N/A
- Revenue Growth
- DERM 2.82
- STEX N/A
- 52 Week Low
- DERM $3.54
- STEX $0.40
- 52 Week High
- DERM $9.40
- STEX $14.11
- Technical
- Relative Strength Index (RSI)
- DERM 48.08
- STEX N/A
- Support Level
- DERM $7.42
- STEX N/A
- Resistance Level
- DERM $8.18
- STEX N/A
- Average True Range (ATR)
- DERM 0.49
- STEX 0.00
- MACD
- DERM -0.11
- STEX 0.00
- Stochastic Oscillator
- DERM 27.00
- STEX 0.00
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About STEX Streamex Corp. Common Stock
Streamex Corp is a Real World Asset (RWA) tokenization company with Institutional grade infrastructure to bring the gold and commodities market on chain. Enabled by a gold denominated treasury and tokenization technology powering the modern commodities market.